This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Espedido, B.
Right arrow Articles by Zelynski, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Espedido, B.
Right arrow Articles by Zelynski, A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, September 2005, p. 4918-4919, Vol. 43, No. 9
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.9.4918-4919.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

Wide Dissemination of a Carbapenemase Plasmid among Gram-Negative Bacteria: Implications of the Variable Phenotype


arrow
LETTER
 
Broad-spectrum carbapenem antibiotics are the last bastion of empirical therapy for resistant gram-negative bacterial infections, and outbreaks of carbapenem-resistant bacterial infection may be associated with greatly increased mortality in the critically ill (4). Carbapenems (e.g., imipenem, meropenem, ertapenem) are increasingly threatened by dissemination of metallo-ß-lactamases (MßLs), the most important of which are the integron-borne members of the VIM and IMP families. Integrons are genetic elements able to capture and express antibiotic resistance determinants in the form of gene cassettes via site-specific recombination (7). Class 1 integrons are dominant among the four classes associated with antibiotic resistance, and plasmids are important vectors for their transmission between bacteria in the hospital environment. While transmissible MßLs are increasingly reported throughout Asia, Europe, and South America, Australia has only recently observed the emergence of an MßL, IMP-4 (5). We found the blaIMP-4 gene cassette as the first of four in a class 1 integron-associated array (GenBank accession no. AJ609296), which also includes an aacA4 gene cassette conferring resistance to gentamicin and tobramycin. This array was present on a large conjugative plasmid (pJIBE401) in a clinical isolate of Klebsiella pneumoniae (Kp1239) referred to our laboratory (2).

With the arrival of a new gene or set of genes in the gram-negative microflora, it is necessary to determine both its transmissibility characteristics and the resulting phenotype to understand the threat it poses. This means assessing the efficiency of transmission and the host range of the transmissible trait, as well as defining the relevant antibiotic resistance phenotype and any potential disadvantage to the organism in terms of growth characteristics or biological fitness (that is, the chance of being segregated out of the microflora by failing to compete in the absence of selection pressure). We therefore mated Kp1239 with rifampin-resistant recipient strains generated from a range of wild-type enteric bacteria, performing conjugation experiments as previously described (1). Transmission of blaIMP-4-bearing plasmid pJIBE401 from Kp1239 into Escherichia coli (EcUB5201Rf) and Enterobacter aerogenes (Ea13048Rf) occurred at a frequency of 10–2, while transmission into Citrobacter freundii (Cf4000Rf) and K. pneumoniae (Kp13883Rf) occurred at frequencies of 10–6 and 10–7, respectively. Serratia marcescens (Sm1002Rf) transconjugants were also generated, at frequencies of ≤10–9 (Table 1). Attempts to introduce pJIBE401 from Kp1239 into Acinetobacter baumannii and Pseudomonas aeruginosa were repeatedly unsuccessful.


View this table:
[in this window]
[in a new window]
 
TABLE 1. MICs of various drugs for the isolates studied

Since the detection of Kp1239, we have observed blaIMP-4 in a number of other enteric bacteria isolated from patients within our region. The clinical isolates K. pneumoniae Kp1239 and Kp2730, Enterobacter cloacae El3518, and Citrobacter amalonaticus Ca3927 are all temporally and geographically distinct and readily separated by DNA fingerprinting (enterobacterial repeat intergenic consensus sequence typing; data not shown) (6). These isolates were used for conjugation experiments into EcUB5201Rf (Table 2). All appeared to have a common high-molecular-weight plasmid of the same size as pJIBE401 (>150 kb; data not shown) carrying identical gene cassettes, consistent with that plasmid's widespread dissemination.


View this table:
[in this window]
[in a new window]
 
TABLE 2. MICs of various drugs for clinical isolates and transconjugants

MICs were determined by Vitek 2 AST-N019 gram-negative susceptibility card (Vitek AMS; BioMérieux Vitek Systems Inc., Hazelwood, Mo.), except for imipenem, which was determined by Etest (AB BIODISK, Solna, Sweden). Most blaIMP-4-bearing transconjugants expressed resistance below the Clinical and Laboratory Standards Institute clinical breakpoint for imipenem sensitivity (Table 1), and we therefore tested whether we could induce higher-level resistance in these strains upon antibiotic exposure in vitro. Kp2730, an imipenem-intermediate (MIC, 8 µg ml–1) clinical isolate, was compared with Kp13883Rf/pJIBE401 transconjugants, which were imipenem sensitive (MIC, 3 µg ml–1; Table 1). Kp2730 (but not Kp13883Rf/pJIBE401) grew as isolated colonies on nutrient agar (Difco) containing 16 µg ml–1 of imipenem, occurring at a frequency of 10–1 to 10–2. A loopful of these colonies was amplified in nutrient broth (Difco) with 16 µg ml–1 of imipenem and further subcultured on 64 µg ml–1 of imipenem in nutrient agar with a 10–1 to 10–2 yield of isolated colonies again (compared with growth on nonselective medium). A loopful of the highly resistant Kp2730-derived mutants (Kp2730R, obtained from the plates containing 64 µg ml–1 of imipenem) was resuspended in nutrient broth, and 100 CFU each of these and of Kp1239, Kp2730, Kp13883Rf, and KP13883Rf/pJIBE401, at log phase, was used to inoculate separate aerobic Bactec 9000 blood culture bottles (BD Diagnostics). All bottles signaled as positive after overnight incubation, with no significant difference in growth rates (Kp1239 and Kp2730 bottles signaled positive at 10 h; Kp13883Rf, KP13883Rf/pJIBE401, and Kp2730R at 11 h), and the high imipenem MICs (≥64 µg ml–1) persisted on subculture.

Decreased outer membrane permeability is one logical explanation for the high carbapenem MICs for some Klebsiella and Enterobacter strains (Tables 1 and 2), but the Kp2730R mutants have not yet been examined in detail. The integron promoter remained unchanged in Kp2730R, and EcUB5201Rf transconjugants displayed little difference in carbapenem MICs as determined by Etests (data not shown), indicating the lack of plasmid involvement in the increased resistance seen. However, ompK36 encodes a porin of known relevance to carbapenem resistance in Klebsiella (3) and we have found this to be disrupted by an insertion sequence in Kp1239 (our unpublished data). Thus, we conclude that a broad-host-range plasmid carrying blaIMP-4 and aacA4 is efficiently transmitted to a wide variety of gram-negative bacteria, that efficiency presumably varying both within and between species, resulting in an elevated MIC of carbapenems which is often still in the sensitive range, but from which stable high-level resistance can be readily selected, at least in some K. pneumoniae strains. This occurs without an obvious growth defect in optimal media and is likely to be clinically important.

The efficient horizontal transfer of resistance genes between gram-negative bacteria in the face of intensive selection pressure in hospitals poses a great problem. The conditional nature of resistance phenotypes such as we describe further complicates infection control measures. Detection of these independent bacterial isolates over the past year suggests dissemination throughout our microflora of a newly arrived panresistance to the main ß-lactams and aminoglycosides. This is a reminder that we need to manage gram-negative resistance surveillance thoughtfully and that we need to think of outbreaks in terms of the transmitted unit (typically a plasmid) and the vagaries of its host range and phenotype.

(These data were presented in part at the Annual Scientific Meeting of the Australian Society for Microbiology, Sydney, Australia, 2004.)


arrow
ACKNOWLEDGMENTS
 
None of the authors have a commercial interest or any other association that might pose a conflict of interest.

B.E. is supported by an Australian Postgraduate Award.


arrow
REFERENCES
 
    1
  1. Dehio, C., and M. Meyer. 1997. Maintenance of broad-host-range incompatibility group P and group Q plasmids and transposition of Tn5 in Bartonella henselae following conjugal plasmid transfer from Escherichia coli. J. Bacteriol. 179:538-540.[Abstract/Free Full Text]
  2. 2
  3. Espedido, B., and J. R. Iredell. Submitted for publication.
  4. 3
  5. Hernandez-Alles, S., V. J. Benedi, L. Martinez-Martinez, A. Pascual, A. Aguilar, J. M. Tomas, and S. Alberti. 1999. Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes. Antimicrob. Agents Chemother. 43:937-939.[Abstract/Free Full Text]
  6. 4
  7. Playford, E. G., J. C. Craig, J. Simpson, and J. R. Iredell. 2003. Abstracts of the 43rd Interscience Conference on Antimicrobial Agents Chemotherapy, abstr. K711. American Society for Microbiology, Washington, D.C.
  8. 5
  9. Poirel, L., J. N. Pham, L. Cabanne, B. J. Gatus, S. M. Bell, and P. Nordmann. 2004. Carbapenem-hydrolysing metallo-ß-lactamases from Klebsiella pneumoniae and Escherichia coli isolated in Australia. Pathology 36:366-367.[CrossRef][Medline]
  10. 6
  11. Rodriguez-Barradas, M., R. Hamill, E. Houston, P. Georghiou, J. Clarridge, R. Regnery, and J. Koehler. 1995. Genomic fingerprinting of Bartonella species by repetitive element PCR for distinguishing species and isolates. J. Clin. Microbiol. 33:1089-1093.[Abstract]
  12. 7
  13. Stokes, H. W., and R. M. Hall. 1989. A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: integrons. Mol. Microbiol. 3:1669-1683.[Medline]
Björn Espedido
Jonathan Iredell*
Lee Thomas

Centre for Infectious Diseases and Microbiology
Westmead Hospital, University of Sydney
Sydney, New South Wales, Australia 2145

Anna Zelynski
Institute for Clinical Pathology and Medical Research
Westmead Hospital
Westmead, New South Wales, Australia 2145

* Phone: 61 2 9845 6255, Fax: 61 2 9891 5317, E-mail: joni{at}icpmr.wsahs.nsw.gov.au


Journal of Clinical Microbiology, September 2005, p. 4918-4919, Vol. 43, No. 9
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.9.4918-4919.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Strahilevitz, J., Jacoby, G. A., Hooper, D. C., Robicsek, A. (2009). Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat. Clin. Microbiol. Rev. 22: 664-689 [Abstract] [Full Text]  
  • van Hal, S. J., Wiklendt, A., Espedido, B., Ginn, A., Iredell, J. R. (2009). Immediate Appearance of Plasmid-Mediated Resistance to Multiple Antibiotics upon Antibiotic Selection: an Argument for Systematic Resistance Epidemiology. J. Clin. Microbiol. 47: 2325-2327 [Abstract] [Full Text]  
  • Liu, Y., Zhang, B., Cao, Q., Huang, W., Shen, L., Qin, X. (2009). Two Clinical Strains of Klebsiella pneumoniae Carrying Plasmid-Borne blaIMP-4, blaSHV-12, and armA Isolated at a Pediatric Center in Shanghai, China. Antimicrob. Agents Chemother. 53: 1642-1644 [Abstract] [Full Text]  
  • Espedido, B. A., Partridge, S. R., Iredell, J. R. (2008). blaIMP-4 in Different Genetic Contexts in Enterobacteriaceae Isolates from Australia. Antimicrob. Agents Chemother. 52: 2984-2987 [Abstract] [Full Text]  
  • Zong, Z., Partridge, S. R., Iredell, J. R. (2008). RmtC 16S rRNA Methyltransferase in Australia. Antimicrob. Agents Chemother. 52: 794-795 [Full Text]  
  • Queenan, A. M., Bush, K. (2007). Carbapenemases: the Versatile {beta}-Lactamases. Clin. Microbiol. Rev. 20: 440-458 [Abstract] [Full Text]  
  • Espedido, B. A., Thomas, L. C., Iredell, J. R. (2007). Metallo-{beta}-Lactamase or Extended-Spectrum {beta}-Lactamase: a Wolf in Sheep's Clothing. J. Clin. Microbiol. 45: 2034-2036 [Abstract] [Full Text]  

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Espedido, B.
Right arrow Articles by Zelynski, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Espedido, B.
Right arrow Articles by Zelynski, A.